123 related articles for article (PubMed ID: 23705497)
1. [Design of deoxyribozymes for inhibition of influenza A virus].
Evdokimov AA; Mazurkova NA; Malygin EG; Zarytova VF; Levina AS; Repkova MN; Zagrebelnyĭ SN; Netesova NA
Mol Biol (Mosk); 2013; 47(1):83-93. PubMed ID: 23705497
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C
Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558
[TBL] [Abstract][Full Text] [Related]
3. Efficient inhibition of influenza A viral replication in cells by deoxyribozymes delivered by nanocomposites.
Repkova M; Levina A; Chelobanov B; Ismagilov Z; Shatskaya N; Baiborodin S; Filippova E; Mazurkova N; Zarytova V
Int J Antimicrob Agents; 2017 Jun; 49(6):703-708. PubMed ID: 28412273
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel benzoquinazolinones and thiazoloimidazoles, inhibitors of influenza H5N1 and H1N1 viruses, from a cell-based high-throughput screen.
Maddry JA; Chen X; Jonsson CB; Ananthan S; Hobrath J; Smee DF; Noah JW; Noah D; Xu X; Jia F; Maddox C; Sosa MI; White EL; Severson WE
J Biomol Screen; 2011 Jan; 16(1):73-81. PubMed ID: 21059874
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activity of novel oseltamivir derivatives against some influenza virus strains.
Kocik J; Kołodziej M; Joniec J; Kwiatek M; Bartoszcze M
Acta Biochim Pol; 2014; 61(3):509-13. PubMed ID: 25210935
[TBL] [Abstract][Full Text] [Related]
6. Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus.
Lejal N; Tarus B; Bouguyon E; Chenavas S; Bertho N; Delmas B; Ruigrok RW; Di Primo C; Slama-Schwok A
Antimicrob Agents Chemother; 2013 May; 57(5):2231-42. PubMed ID: 23459490
[TBL] [Abstract][Full Text] [Related]
7. H5N1 Influenza A Virus PB1-F2 Relieves HAX-1-Mediated Restriction of Avian Virus Polymerase PA in Human Lung Cells.
Mazel-Sanchez B; Boal-Carvalho I; Silva F; Dijkman R; Schmolke M
J Virol; 2018 Jun; 92(11):. PubMed ID: 29563290
[TBL] [Abstract][Full Text] [Related]
8. Antiviral resistance due to deletion in the neuraminidase gene and defective interfering-like viral polymerase basic 2 RNA of influenza A virus subtype H3N2.
Trebbien R; Christiansen CB; Fischer TK
J Clin Virol; 2018 May; 102():1-6. PubMed ID: 29448067
[TBL] [Abstract][Full Text] [Related]
9. Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis.
Vanderlinden E; Vrancken B; Van Houdt J; Rajwanshi VK; Gillemot S; Andrei G; Lemey P; Naesens L
Antimicrob Agents Chemother; 2016 Nov; 60(11):6679-6691. PubMed ID: 27572398
[TBL] [Abstract][Full Text] [Related]
10. Human miR-3145 inhibits influenza A viruses replication by targeting and silencing viral PB1 gene.
Khongnomnan K; Makkoch J; Poomipak W; Poovorawan Y; Payungporn S
Exp Biol Med (Maywood); 2015 Dec; 240(12):1630-9. PubMed ID: 26080461
[TBL] [Abstract][Full Text] [Related]
11. Cryptoporic acid E from Cryptoporus volvatus inhibits influenza virus replication in vitro.
Gao L; Han J; Si J; Wang J; Wang H; Sun Y; Bi Y; Liu J; Cao L
Antiviral Res; 2017 Jul; 143():106-112. PubMed ID: 28232246
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive surveillance of adamantane resistance among human influenza A virus isolated from mainland China between 1956 and 2009.
Lan Y; Zhang Y; Dong L; Wang D; Huang W; Xin L; Yang L; Zhao X; Li Z; Wang W; Li X; Xu C; Yang L; Guo J; Wang M; Peng Y; Gao Y; Guo Y; Wen L; Jiang T; Shu Y
Antivir Ther; 2010; 15(6):853-9. PubMed ID: 20834097
[TBL] [Abstract][Full Text] [Related]
13. Influenza virus segment 5 (+)RNA - secondary structure and new targets for antiviral strategies.
Soszynska-Jozwiak M; Michalak P; Moss WN; Kierzek R; Kesy J; Kierzek E
Sci Rep; 2017 Nov; 7(1):15041. PubMed ID: 29118447
[TBL] [Abstract][Full Text] [Related]
14. Anti-influenza virus activity of a salcomine derivative mediated by inhibition of viral RNA synthesis.
Takizawa N; Kimura T; Watanabe T; Shibasaki M
Arch Virol; 2018 Jun; 163(6):1607-1614. PubMed ID: 29497849
[TBL] [Abstract][Full Text] [Related]
15. Antiviral Activity of 3D, a Butene Lactone Derivative Against Influenza A Virus In Vitro and In Vivo.
Wang Z; Fang J; Luo J; Hou D; Tan Y; Gu Z; Ge Y; Mao L; Liu L; Liu H; Wei Z; Xu H
Viruses; 2021 Feb; 13(2):. PubMed ID: 33670217
[TBL] [Abstract][Full Text] [Related]
16. siRNAs targeting PB2 and NP genes potentially inhibit replication of Highly Pathogenic H5N1 Avian Influenza Virus.
Behera P; Nagarajan S; Murugkar HV; Kalaiyarasu S; Prakash A; Gothalwal R; Dubey SC; Kulkarni DD; Tosh C
J Biosci; 2015 Jun; 40(2):233-40. PubMed ID: 25963253
[TBL] [Abstract][Full Text] [Related]
17. Anti-influenza virus effects of cocoa.
Kamei M; Nishimura H; Takahashi T; Takahashi N; Inokuchi K; Mato T; Takahashi K
J Sci Food Agric; 2016 Mar; 96(4):1150-8. PubMed ID: 25847473
[TBL] [Abstract][Full Text] [Related]
18. An oligothiophene compound neutralized influenza A viruses by interfering with hemagglutinin.
Shen X; Zhu Z; Ding Y; Wu W; Yang J; Liu S
Biochim Biophys Acta Biomembr; 2018 Mar; 1860(3):784-791. PubMed ID: 29229526
[TBL] [Abstract][Full Text] [Related]
19. A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1.
Duwe S; Schweiger B
J Virol Methods; 2008 Nov; 153(2):134-41. PubMed ID: 18725246
[TBL] [Abstract][Full Text] [Related]
20. The Human Antimicrobial Protein Bactericidal/Permeability-Increasing Protein (BPI) Inhibits the Infectivity of Influenza A Virus.
Pinkenburg O; Meyer T; Bannert N; Norley S; Bolte K; Czudai-Matwich V; Herold S; Gessner A; Schnare M
PLoS One; 2016; 11(6):e0156929. PubMed ID: 27273104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
